Fidelis Capital Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $269K | Sell |
3,653
-9
| -0.2% | -$662 | 0.02% | 370 |
|
|
2025
Q1 | $255K | Buy |
3,662
+746
| +26% | +$51.9K | 0.03% | 352 |
|
|
2024
Q4 | $204K | Sell |
2,916
-14,575
| -83% | -$1.02M | 0.02% | 420 |
|
|
2024
Q3 | $1.35M | Buy |
17,491
+1,478
| +9% | +$114K | 0.16% | 118 |
|
|
2024
Q2 | $1.29M | Buy |
16,013
+4,932
| +45% | +$398K | 0.18% | 96 |
|
|
2024
Q1 | $751K | Buy |
11,081
+5,745
| +108% | +$389K | 0.11% | 165 |
|
|
2023
Q4 | $359K | Buy |
5,336
+939
| +21% | +$63.2K | 0.08% | 216 |
|
|
2023
Q3 | $298K | Buy |
4,397
+968
| +28% | +$65.6K | 0.1% | 197 |
|
|
2023
Q2 | $245K | Buy |
3,429
+733
| +27% | +$52.5K | 0.09% | 234 |
|
|
2023
Q1 | $203K | Buy |
+2,696
| New | +$203K | 0.09% | 236 |
|